Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 701 - 750 out of 13,930

Document Document Title
WO/2011/106992
Disclosed are compounds of formula (I) that are used as hepatitis C virus (HCV) NS5B polymerase inhibitors, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NS5B polymerase activity, for treating or preve...  
WO/2011/107720
The invention relates to a mixture including: protolichesterinic acid or one of the salts, diastereoisomers or derivatives thereof; and lichesterinic acid or one of the salts, enantiomers or derivatives thereof, to be used for stimulatin...  
WO/2011/106929
Compounds of formula I that are used as hepatitis C virus (HCV) NS5B polymerase inhibitors, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NS5B polymerase activity, for treating or preventing HCV infect...  
WO/2011/106986
Compounds of formula (I) that are used as hepatitis C virus (HCV) NS5B polymerase inhibitors, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NS5B polymerase activity, for treating or preventing HCV infe...  
WO/2011/106992
Disclosed are compounds of formula (I) that are used as hepatitis C virus (HCV) NS5B polymerase inhibitors, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NS5B polymerase activity, for treating or preve...  
WO/2011/104591
The invention relates to a new process for the preparation of dronedarone and its salts, in particular a synthesis process which allows said compound and its salts to be obtained with good yields, high purity and in an industrially exped...  
WO/2011/101229
The present invention relates to compounds of formula (I) wherein Q is Q1 or Q2 P is P1, heterocyclylor heterocyclyl substituted by one to five Z; and wherein A1, A2, A3, A4, G1, Y1, Z, R1, R2, R3 and R4 are as defined in claim 1; or a s...  
WO/2011/102112
An aromatic amine derivative represented by formula (1) (wherein L represents a linking group; Z represents a group represented by formula (2); and A1 and A2 independently represent a monovalent group represented by formula (3)).  
WO/2011/102806
A process of making entecavir comprising converting a compound of formula (M5) to entecavir, wherein the two PGs on the formula (M5) are taken together to form an optionally substituted six- or seven-member cyclic ring.  
WO/2011/099443
Disclosed is a method for producing a β-dihydrofuran deriving compound or a β-tetrahydrofuran deriving compound represented by formula (1) or (4), which is characterized by having a dialkyl dicarbonate, a diaralkyl dicarbonate or a hal...  
WO/2011/098030
Disclosed are bianthracene compounds substituted by aromatic rings and their uses as luminescence materials which belong to the synthetic field of organic electroluminescence material. The said compounds have high glass-transition temper...  
WO/2011/098440
The invention relates to novel compounds of formula (I), where W, X, Y, Z, and CKE have the meanings indicated above, to a plurality of methods and intermediate products for production same, and to the use thereof as pesticides and/or he...  
WO/2011/100601
The application is directed to a process for the production of a biobased gamma -butyrolactone product, comprising combining a genetically engineered biomass comprising poly- 4 -hydroxy-butyrate and a catalyst, and heating the biomass wi...  
WO/2011/098440
The invention relates to novel compounds of formula (I), where W, X, Y, Z, and CKE have the meanings indicated above, to a plurality of methods and intermediate products for producing same, and to the use thereof as pesticides and/or her...  
WO/2011/100601
The application is directed to a process for the production of a biobased gamma -butyrolactone product, comprising combining a genetically engineered biomass comprising poly- 4 -hydroxy-butyrate and a catalyst, and heating the biomass wi...  
WO/2011/095462
The present invention relates to certain bisamide derivatives of formula (I), to processes and intermediates for preparing them, to insecticidal, acaricidal, nematicidal or molluscicidal compositions comprising them and to methods of usi...  
WO/2011/095461
The present invention relates to novel pyridazine derivatives of formula (I) wherein R1 is methyl or ethyl; R2 is H or chloro; R3 is fluoro or chloro; R4 is fluoro or methoxy; and R5 is chloro or methoxy or an agrochemically usable salt ...  
WO/2011/094890
Provided herein are non-peptide GLP-1 receptor modulator compounds, for example, of Formula (I), pharmaceutical compositions comprising such compounds, and processes of preparation thereof. Also provided are methods of their use for the ...  
WO/2011/096506
Provided is an aminoanthracene derivative represented by formula (1) and having an end substituent, e.g., a dibenzofuran ring, bonded in a position other than the 2-position to the anthracene through a nitrogen atom. Also provided is an ...  
WO/2011/092611
Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula (I) as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, met...  
WO/2011/090149
An aromatic amine derivative having a terminal substituent selected from a dibenzofuran, a dibenzothiophene, a substituted carbazole and a substituted fluorene bound to the central skeleton having a specific structure through a nitrogen ...  
WO/2011/085979
A compound of the formula I, wherein the symbols are as defined in the remaining specification, or a mixture of two or more compounds of the formula I, for use as active ingredient in the therapeutic - including prophylactic - treatment ...  
WO/2011/085979
A compound of the formula I, wherein the symbols are as defined in the remaining specification, or a mixture of two or more compounds of the formula I, for use as active ingredient in the therapeutic - including prophylactic - treatment ...  
WO/2011/084098
Processes for making 7-methyl-5-(3piperazin-1-ylmethyl-[1,2,4]oxadiazol-5-yl)-2-( 4- trifluoromethoxybenzyl)-2,3-dihydroisoindol-1-one  
WO/2011/082506
A method for preparing Aliskiren and intermediate thereof, which comprises the following steps: reacting 4-bromo-1-methoxy-2-(3-methoxypropoxy)benzene with magnesium isopropyl chloride and n-BuLi to obtain the compound of formula XXII; r...  
WO/2011/083346
The subject of the present invention is a novel process for the preparation of N- [2-n-butyl-3-{4-[(3-dibutylamino)propoxy]benzoyl}-1-benzofur an-5- yl] methanesulfonamide of formula (I) and the new intermediates of the reparation process.  
WO/2011/084649
Redox flow devices are described in which at least one of the positive electrode or negative electrode-active materials is a semi-solid or is a condensed ion-storing electroactive material, and in which at least one of the electrode-acti...  
WO/2011/075784
The present invention provides novel compounds of the Formula (I), pharmaceutical compositions comprising such compounds and methods for using such compounds as agents or drugs for inhibiting perforin activity and for treating a subject ...  
WO/2011/076736
A process for preparing a hydrocarbon or mixture of hydrocarbons comprising the steps of (i) hydrogenating furfural, 5-hydroxymethylfurfural or a mixture of furfural and 5-hydroxymethylfurfural to provide furfuryl alcohol, 2, 5-furandime...  
WO/2011/078387
Disclosed is a composition which contains (i) a crosslinkable high-molecular-weight compound that has a crosslinkable group and exhibits either light emitting properties and/or charge transporting properties, and (ii) a crosslinkable low...  
WO/2011/076679
The invention relates to a method for producing aromatic and heteroaromatic carbolic acids using CO2.  
WO/2011/073253
The present invention provides a method for producing furfural from lignocellulosic biomass material, comprising the steps of: (a) contacting the lignocellulosic biomass material with a mixture comprising water and an organic acid at a t...  
WO/2011/075634
The present invention is directed to novel bicyclic derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by DPP-1.  
WO/2011/074550
Disclosed is an organic electroluminescent element which has high driving stability and long service life. The organic electroluminescent element can be produced at low cost by forming a light-emitting layer using a composition for light...  
WO/2011/073387
A process for the preparation of β,γ-unsaturated-γ,γ-disubstituted esters 1 with high E/Z- and β,γ/α,β-ratios, Formula (1) by reacting at a temperature of between about 130 and 170 degrees centigrade the conjugated malonate Formu...  
WO/2011/071136
A therapeutic agent for fibromyalgia, comprising a 5-HT2C receptor agonist as an active ingredient.  
WO/2011/070030
The present invention relates to compounds of formula (I) and pharmaceutically acceptable salts thereof. The compounds have been demonstrated as inhibitors of MEK and therefore may be useful in the treatment of hyperproliferative disease...  
WO/2011/070152
The present invention relates to novel antiviral compounds, which are aryl 3-deazauridine analogues at the C3 position, to a method for synthesizing said compounds, as well as to the antiviral uses thereof. The compounds are of the gener...  
WO/2011/070380
The subject of the present invention is a novel process for the preparation of N- [2-n-butyl-3-{4-[(3-dibutylamino)propoxy]benzoyl}-1-benzofur an-5- yl] methanesulfonamide of formula (I) and the new intermediates of the preparation process.  
WO/2011/071048
Provided is an agent which is a novel drug for the treatment or prevention of diabetes in that the agent possesses serine protease-inhibiting activity and thereby inhibits an increase in the blood glucose level. The agent is a compound r...  
WO/2011/070459
The present invention relates to a novel manufacturing process and novel intermediates useful in the synthesis of pharmaceutically active compounds, especially rennin inhibitors such as Aliskiren. The invention describes a preparation of...  
WO/2011/071503
The present invention provides a method for depolymerization of a mixture comprising oligomeric cyclic ethers resulting from copolymerization of at least one tetrahydrofuran and at least one other cyclic ether to recover tetrahydrofuran ...  
WO/2011/069039
Disclosed herein are novel hydrazone and diacyl hydrazine derivatives that are inhibitors of the endoplasmic reticulum-associated protein degradation (ERAD) pathway. Also disclosed are hydrazone and diacyl hydrazine derivatives as potent...  
WO/2011/063500
A process for producing furfural involves dehydrating xylose at elevated temperature with a heterogeneous catalyst comprising a sulfonated tetrafluoroethylene-based fluoropolymer-copolymer. The sulfonated tetrafluoroethylene-based fluoro...  
WO/2011/066184
The present invention relates to novel amine derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals as modulators of sphingosine-1 -phosphate receptors.  
WO/2011/061590
The present invention relates to carboxamide derivatives of Formula (I), where B1, B2, X, L, n, R, R1, R2, Z1, Z2, Rx and Ry are as defined in the claims, as compounds and compositions for inhibiting Human Immunodeficiency Virus (HIV) an...  
WO/2011/060877
The invention relates to organic light emitting devices containing fluorene derivatives and spirobifluorene derivatives as matrix material for phosphorescent emitters.  
WO/2011/062280
Disclosed is a method for obtaining an optically active alcohol by highly enantioselective secondary alkylation, while suppressing side reactions. Specifically disclosed is a method for producing an optically active alcohol, which compri...  
WO/2011/059099
Disclosed is an aromatic amine derivative represented by the formula N(ArA)(ArB)(ArC), which can be used as an organic EL element material that enables the reduction in voltage and the improvement in luminous efficiency and service life ...  
WO/2011/057332
New clerodane compounds isolated from plant material from Dodonaea polyandra are disclosed. The compounds have anti-inflammatory activity. Pharmaceutical and cosmetic compositions containing the compounds, as well as methods of treating ...  

Matches 701 - 750 out of 13,930